Your browser doesn't support javascript.
loading
A Seroprevalence Study on Residents in a Senior Care Facility with Breakthrough SARS-CoV-2 Omicron Infection.
Kim, Heui Man; Lee, Eun Ju; O, Sang Won; Choi, Yong Jun; Lee, Hyeokjin; Oh, Sae Jin; Kim, Jeong-Min; Park, Ae Kyung; Kim, Jeong-Ah; Lee, Chae Young; Kim, Jong Mu; Park, Hanul; Park, Young Joon; Yu, Jeong-Hee; Kim, Eun-Young; Ko, Hwa-Pyeong; Kim, Eun-Jin.
Afiliação
  • Kim HM; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Republic of Korea.
  • Lee EJ; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Republic of Korea.
  • O SW; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Republic of Korea.
  • Choi YJ; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Republic of Korea.
  • Lee H; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Republic of Korea.
  • Oh SJ; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Republic of Korea.
  • Kim JM; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Republic of Korea.
  • Park AK; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Republic of Korea.
  • Kim JA; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Republic of Korea.
  • Lee CY; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Republic of Korea.
  • Kim JM; Epidemiological Investigation Team, Epidemiological Investigation and Analysis Task Force, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Republic of Korea.
  • Park H; Epidemiological Investigation Team, Epidemiological Investigation and Analysis Task Force, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Republic of Korea.
  • Park YJ; Epidemiological Investigation Team, Epidemiological Investigation and Analysis Task Force, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Republic of Korea.
  • Yu JH; Honam Regional Center for Disease Control and Prevention, Gwangju-si, Republic of Korea.
  • Kim EY; Honam Regional Center for Disease Control and Prevention, Gwangju-si, Republic of Korea.
  • Ko HP; Gwangju Metropolitan Government, Gwangju-si, Republic of Korea.
  • Kim EJ; Division of Emerging Infectious Diseases, Bureau of Infectious Diseases Diagnosis Control, Korea Disease Control and Prevention Agency (KDCA), Cheongju-si, Republic of Korea.
Viral Immunol ; 36(3): 203-208, 2023 04.
Article em En | MEDLINE | ID: mdl-36951666

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Aged / Humans Idioma: En Revista: Viral Immunol Assunto da revista: ALERGIA E IMUNOLOGIA / VIROLOGIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Aged / Humans Idioma: En Revista: Viral Immunol Assunto da revista: ALERGIA E IMUNOLOGIA / VIROLOGIA Ano de publicação: 2023 Tipo de documento: Article